gastroesophageal reflux disease (GERD)

Biotech

Phathom's erosive esophagitis drug bests Prevacid in phase 3

Phathom Pharmaceuticals' erosive esophagitis drug vonoprazan performed as well as over-the-counter Prevacid in a head-to-head phase 3 clinical trial.
Emmy Lucas Oct 18, 2021 3:10pm

Neurogastrx bags $60M to join crowded gastrointestinal field

Aug 26, 2021 6:30am
image-icon

2020’s top 10 clinical trial flops

Jan 25, 2021 3:00am

Ironwood cuts GERD hopeful along with 100 staffers

Sep 29, 2020 11:27am

Pear teams up with Ironwood for GI-focused digital treatments

Oct 30, 2019 10:20am

J&J leads $7M round for digital health co. Cara Care

Jun 18, 2019 10:53am